Founded by Professor Ed Southern, Oxford Gene Technology (OGT) is focused on providing innovative clinical genetics and diagnostic solutions to advance molecular medicine.
OGT’s innovative portfolio includes:
CytoSure™ — Providing clinical researchers with the complete array solution for the detection of chromosomal abnormalities, including class-leading products and fully accredited services, underpinned by exceptional interpretation software.
Genefficiency™ — Delivering comprehensive, high-quality microarray and targeted sequencing services to clinical and academic researchers.
Diagnostic Biomarkers — Providing tailored biomarker discovery solutions that optimise drug and diagnostic development programmes for pharmaceutical and molecular diagnostic companies.
Oxford Gene Technology (OGT) has released a new white paper discussing the relative merits of DNA microarrays and next generation sequencing (NGS) for human...